Pegavision Corporation (6491.TW) Stock
Pegavision Corporation

Company profile
Pegavision reported revenue of 7.04 billion TWD for fiscal year 2025, up 3.3% from fiscal year 2024, and net income of 1.63 billion TWD. That is a net profit margin of 23.1% for fiscal year 2025. Asia and Other Countries was its largest region in fiscal year 2025, with 79% of revenue. Our analysis of its filings shows revenue growing from 6.79 billion TWD in fiscal year 2023 to 7.04 billion TWD in fiscal year 2025, 1.8% a year on average.
What stands out
- Revenue in fiscal year 2025 was the highest of the last 5 fiscal years.
Figures from company filings; latest fiscal year ended December 31, 2025.
About Pegavision Corporation
Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation operates as a subsidiary of Pegatron Corporation.
Largest shareholders
- Kinsus Interconnect Technology Corp.27.22%
- Pegatron Corporation8.17%
- Ming Tung Kuo1.699 %1.70%
- Tzu Hsien Tung1.412 %1.41%
- Te Sheng Yang0.3864 %0.39%
Share of the company, as of September 25, 2026
Leadership
- Te-Sheng Yang — President & Representative Director
- Ming-Dong Kuo — Chairman of the Board & Chief Strategy Officer
- Tony Wang — Senior Director of Finance & Accounting Div., Accounting Supervisor and Corporate Governance Officer
- Terry Chang — Vice President
- Yi-Hong Pan — Deputy General Manager
How much revenue does Pegavision make?
Pegavision reported 7.04 billion TWD in revenue for fiscal year 2025, up 3.3% from 6.82 billion TWD in fiscal year 2024.
Where does Pegavision make most of its revenue?
Asia and Other Countries: 79% of revenue by region in fiscal year 2025, followed by Taiwan (14%).
What companies are similar to Pegavision?
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Visco Vision Inc. (6782.TW), Vizionfocus Inc. (4771.TW), St.Shine Optical Co.,Ltd. (1565.TWO), Icares Medicus, Inc. (6612.TWO).
How has Pegavision's revenue changed over the last 5 fiscal years?
Revenue by fiscal year: FY2021, 5.60 billion TWD; FY2022, 6.32 billion TWD; FY2023, 6.79 billion TWD; FY2024, 6.82 billion TWD; FY2025, 7.04 billion TWD.
Data as of .
How to cite: DataPorium, “Pegavision Corporation (6491.TW)”, data as of Sep 25, 2026, https://dataporium.tech/stocks/6491.TW